Cannindah Resources Limited (ASX: CAE) has reported standout trenching results from the Southern Target Zone (Appletree–Dunno) at Mt Cannindah, Queensland (Figure 1). The work outlines a 500 m × 100 m corridor of high-order Cu-Au-Mo geochemistry coincident with IP chargeability and magnetic highs—and crucially, an untested target at the lowest topographic level within the mining leases, consistent with a preserved porphyry system.

AML3D Limited (ASX: AL3) will supply two custom ARCEMY® systems to Newport News Shipbuilding, extending its footprint in US naval supply chains. The order value is ~A$4.5m, reinforcing momentum after multiple ARCEMY® deployments into the US Navy’s Maritime Industrial Base. The company expects the units to be installed and operational in Q2 2026.

Meta description 145 Explore OD6 Metals' innovative REE strategies on Coffee with Samso. Discover how their REE advancements and copper potential redefine the market.

Kaiser Reef Limited (ASX: KAU) has reported materially higher processing performance and a coordinated ramp-up program at the Henty Gold Mine in Tasmania (Figure 1), alongside actions to de-bottleneck underground access, modernise the fleet, and accelerate resource growth drilling. Management frames these steps as critical to lowering unit costs and underpinning near-term Reserve calculations.

Pivotal Metals Limited (ASX: PVT) has released new Fixed-Loop Time Domain EM (FLTEM) results from the Midrim–Alotta area of the Belleterre-Angliers Greenstone Belt (BAGB) Projects in Abitibi, Québec, Canada, ~85 km south of Rouyn-Noranda (Figure 1). The work defines a substantial, untested conductive plate directly beneath the shallow, high-grade Alotta sulphide body, and indicates prior drilling was sub-optimal; a new NE-oriented drill strategy is now planned to test depth

Actinogen Medical (ASX: ACW) released two important updates dated 20 October 2025: (1) accelerated recruitment has enabled early closure of pTau screening for the Phase 2b/3 XanaMIA Alzheimer’s trial; and (2) an Advance Overseas Finding (AOF) approval confirms eligibility for a further RDTI rebate of ~$1.87m, taking the total FY25 RDTI to ~$7.36m if the ATO amendment is favourably assessed.

archTIS Limited ((ASX: AR9) has announced a second U.S. Department of Defense–related contract, this time to deliver customised development work on its NC Protect product for the Microsoft DoD365 environment via federal contractor Copper River Technologies. While modest in dollar terms, management frames this engagement as a bridge that advances enterprise-grade rollout and positions the company for a larger licensing outcome already flagged earlier in the year.

Proteomics International (ASX: PIQ) has expanded its research agreement with the University of Melbourne and the Royal Women’s Hospital (RWH), a leading centre for endometriosis research. The partnership has two clear streams: (1) additional clinical validation for Promarker®Endo—PIQ’s first-in-class blood test for diagnosing endometriosis—and (2) discovery work toward a tissue-specific, next-generation test using peritoneal fluid to improve disease localisation.

Medibank Private has expanded its multi-year funding agreement with Emyria Limited (ASX: EMD) to support screened and eligible customers accessing Empax programs for Treatment-Resistant Depression (TRD) and Post-Traumatic Stress Disorder (PTSD) at Avive Clinic Brisbane (Figure 1). Clinic fit-out and regulatory preparations are underway, with treatment commencement targeted for Q4 CY2025. This marks Emyria’s first insurer-backed program on Australia’s east coast and advances t

Xstate Resources Limited (ASX: XST) has provided an operations update for Diona-1 within the Diona block, ATP 2077, in the Surat–Bowen Basin, Queensland (Figure 1). As at the time of writing, the well had reached 2,479 m MD, intersected its Jurassic primary target (non-hydrocarbon-bearing), and on entering the Permian encountered an ~181 m hydrocarbon-prone sequence with a significant overpressured gas column.

Encounter Resources Limited (ASX: ENR)’s latest Aileron results sharpen the focus on Green Prospect (Figure 1) as the emerging high-grade core of this West Arunta carbonatite system. A standout 85m @ 3.1% Nb₂O₅ within a thicker 124m envelope materially upgrades grade continuity inside—and beyond—the current resource shell.

Algorae Pharmaceuticals Ltd (ASX: 1AI) has executed a binding term sheet with Cadila Pharmaceuticals Limited for a proposed license and supply agreement covering Australia and New Zealand. The partnership would see Algorae launch two generic medicines targeting cardiovascular and metabolic disorders, with next steps focused on finalising a definitive agreement and preparing for TGA registration.